Canine cutaneous mast cell tumors

被引：0

作者：

Van Eetvelde, L. ^{[1
]}

Chiers, K. ^{[1
]}

Van Brantegem, L. ^{[1
]}

机构：

[1] Univ Ghent, Fac Diergeneeskunde, Vakgrp Pathol Bacteriol & Pluimveeziekten, Salisburylaan 133, B-9820 Merelbeke, Belgium

来源：

VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT | 2017年 / 86卷 / 05期

关键词：

PROGNOSTIC-FACTORS; DOUBLE-BLIND; DOGS; SURVIVAL; THERAPY; MASTOCYTOSIS; EXPRESSION; BEHAVIOR; FEATURES; SPLEEN;

D O I：

10.21825/vdt.v86i5.16171

中图分类号：

S85 [动物医学（兽医学）];

学科分类号：

0906 ;

摘要：

Canine cutaneous mast cell tumors (cMCT) are a commonly encountered neoplasia in small animal practice. Ninety-six percent of the cMCT can be diagnosed with cytology. Because of the variating biological character, it's difficult to establish a prognosis. Therefore, the prognosis is assessed with multiple prognostic factors: tumor location, systemic complaints, metastases, histological and cytological grading, proliferation markers, KIT-staining pattern, KIT-mutation and tumor free margins. The treatment of choice is based upon the results of these prognostic factors, the clinical stage and the tumor location. Possible treatments include surgery, radiotherapy, chemotherapy, electrochemotherapy, tyrosine kinase inhibitors, cryotherapy and intraregional therapy with deionized water.

引用

页码：311 / 321

页数：11

共 48 条

[1] Soft tissue sarcomas and mast cell tumours in dogs; clinical behaviour and response to surgery [J].

Baker-Gabb, M ;

Hunt, GB ;

France, MP .

AUSTRALIAN VETERINARY JOURNAL, 2003, 81 (12) :732-738

[2]

Berlato D., 2017, GRADING CANINE CUTAN

[3] European consensus document on mast cell tumours in dogs and cats [J].

Blackwood, L. ;

Murphy, S. ;

Buracco, P. ;

De Vos, J. P. ;

De Fornel-Thibaud, P. ;

Hirschberger, J. ;

Kessler, M. ;

Pastor, J. ;

Ponce, F. ;

Savary-Bataille, K. ;

Argyle, D. J. .

VETERINARY AND COMPARATIVE ONCOLOGY, 2012, 10 (03) :e1-e29

[4] Hypotonic water as adjuvant therapy for incompletely resected canine mast cell tumors: A randomized, double-blind, placebo-controlled study [J].

Brocks, Bouvien A. W. ;

Neyens, Isabelle J. S. ;

Teske, Erik ;

Kirpensteijn, Jolle .

VETERINARY SURGERY, 2008, 37 (05) :472-478

[5] Cytologic Criteria for Mast Cell Tumor Grading in Dogs With Evaluation of Clinical Outcome [J].

Camus, M. S. ;

Priest, H. L. ;

Koehler, J. W. ;

Driskell, E. A. ;

Rakich, P. M. ;

Ilha, M. R. ;

Krimer, P. M. .

VETERINARY PATHOLOGY, 2016, 53 (06) :1117-1123

[6]

Dank G, 2016, ISR J VET MED, V71, P3

[7] Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumors [J].

Davies, David R. ;

Wyatt, Kenneth M. ;

Jardine, John E. ;

Robertson, Ian D. ;

Irwin, Peter J. .

JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION, 2004, 40 (02) :124-130

[8] CUTANEOUS MASTOCYTOSIS IN A DOG [J].

DAVIS, BJ ;

PAGE, R ;

SANNES, PL ;

MEUTEN, DJ .

VETERINARY PATHOLOGY, 1992, 29 (04) :363-365

[9] Mast cell leukemia in a dog [J].

De Bossehere, H. ;

Deloose, S. .

VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT, 2009, 78 (01) :49-52

[10] Advances in the diagnosis and management of cutaneous mast cell tumours in dogs [J].

Dobson, J. M. ;

Scase, T. J. .

JOURNAL OF SMALL ANIMAL PRACTICE, 2007, 48 (08) :424-431

← 1 2 3 4 5 →